Skip to content
naulon
Not checkedNot checked for notices yet.

Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response

Stephen Pierce, Eric S. Geanes, Todd Bradley and 2 more

Frontiers in Cellular and Infection Microbiology · 2020

doi:10.3389/fcimb.2020.00231 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Natural killer (NK) cells are critical for targeting and killing tumor, virus-infected and stressed cells as a member of the innate immune system. Recently, NK cells have also emerged as key regulators of adaptive immunity and have become a prominent therapeutic target for cancer immunotherapy and infection control. NK cells display a diverse array of phenotypes and function. Determining how NK cells develop and are regulated is critical for understanding their role in both innate and adaptive immunity. In this review we discuss current research approaches into NK cell adaptive immunity and how these cells are being harnessed for improving cancer and vaccination outcomes.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.